Shilpa Medicare Ltd.

₹642.55

Shilpa Medicare Ltd.

₹642.55

₹642.55

32.9 (5.4%) - 8 Apr 2025 04:25 PM

About Company

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Presently, the company is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Market Cap. ₹5,962 Cr.
52 Week - High/Low ₹960/418
P/E Ratio 69.04
P/B Ratio 2.78
Enterprise Value ₹6,008 Cr.
ROE % 1.26
RSI Value 39.01
EMA 50 683.09
EMA 200 698.42
Net Profit 27 Cr.
Net Profit 3year growth -85.39 Cr.
Net Profit 3 year (back) 184 Cr.
Debt to Equity 0.07 %
EPS Growth TTM -754.07 %
Current Ratio 1.67 %
100 Day SMA 753 Rs.
200 Day SMA 751 Rs.
21 Day SMA 660 Rs.
50 Day SMA 672 Rs.
Book Value 219 Rs.
EV/EBITDA Ratio 33
QoQ EPS Growth -47 %
QoQ Operating Profit Growth -48 %
QoQ Sales Growth -3 %
Sales Latest Quarter 125 Cr.
YoY Sales Growth 96 %
Market Cap. ₹5,962 Cr.
52 Week - High/Low ₹960/418
P/E Ratio 65.13
P/B Ratio 3.30
Enterprise Value ₹6,521 Cr.
ROE % 1.78
RSI Value 39.01
EMA 50 683.09
EMA 200 698.42
Net Profit 32 Cr.
Net Profit 3year growth 40.45 Cr.
Net Profit 3 year (back) 148 Cr.
Debt to Equity 0.52 %
EPS Growth TTM -13471.43 %
Current Ratio 1.26 %
100 Day SMA 753 Rs.
200 Day SMA 751 Rs.
21 Day SMA 660 Rs.
50 Day SMA 672 Rs.
Book Value 185 Rs.
EV/EBITDA Ratio 20
QoQ EPS Growth 77 %
QoQ Operating Profit Growth -5 %
QoQ Sales Growth -7 %
Sales Latest Quarter 319 Cr.
YoY Sales Growth 11 %

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.